CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Web-based Surveyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03906214
NCT03906214N/ACompleted

Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

University of South Florida·observational·Posted Apr 8, 2019·Updated Oct 16, 2019

In Brief

An observational study evaluating Web-based Survey for Porphyrias. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consortium. The study will be advertised on the Consortium website and through the American Porphyria Foundation's social media network.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 8, 2019
Enrollment StartApr 3, 2019
Primary CompletionSep 13, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.2 years ago

Interventions

Web-based Surveyother

Participants will be directed to online forms to report general information (ex. age, sex, test results, family history), suspected medication-related acute attacks, and "uneventful use of possibly risky medication". If a patient has multiple medication-related acute attacks, the patient/caregiver will be able to submit multiple report forms that will be linked. In addition to the report forms, patients will be asked to review a list of "Medications of Interest" and report current or past use.